Advertisement

The role of total intravenous anaesthesia for caesarean delivery

Published:April 08, 2022DOI:https://doi.org/10.1016/j.ijoa.2022.103548

      Highlights

      • Total intravenous anaesthesia is used infrequently for caesarean delivery.
      • Total intravenous anaesthesia may confer benefit in obstetric anaesthesia.
      • Practical barriers to total intravenous anaesthesia in obstetrics must be addressed.

      Abstract

      Obstetric general anaesthesia technique usually involves intravenous induction and maintenance with volatile agents. Total intravenous anaesthesia has gained in popularity in non-obstetric practice because of environmental concerns associated with volatile inhalational anaesthetics and evidence of a superior recovery profile. Publications on the use of total intravenous anaesthesia for caesarean delivery are sparse. The limited evidence suggests that total intravenous anaesthesia may confer benefits for caesarean delivery, including reducing the risk of haemorrhage. However, there are practical barriers to utilising total intravenous anaesthesia in obstetric anaesthesia. We discuss the evidence and potential role of total intravenous anaesthesia for caesarean delivery.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Obstetric Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bamber J.H.
        • Lucas D.N.
        • Plaat F.
        • Russell R.
        Obstetric anaesthetic practice in the UK: a descriptive analysis of the National Obstetric Anaesthetic Database 2009–14.
        Br J Anaesth. 2020; 125: 580-587
        • Juang J.
        • Gabriel R.A.
        • Dutton R.P.
        • Palanisamy A.
        • Urman R.D.
        Choice of anesthesia for cesarean delivery: an analysis of the National Anesthesia Clinical Outcomes Registry.
        Anesth Analg. 2017; 124: 1914-1917
        • Sury M.R.J.
        • Palmer J.H.M.G.
        • Cook T.M.
        • Pandit J.J.
        The state of UK anaesthesia: a survey of National Health Service activity in 2013.
        Br J Anaesth. 2014; 113: 575-584
        • Al-Rifai Z.
        • Mulvey D.
        Principles of total intravenous anaesthesia: practical aspects of using total intravenous anaesthesia.
        BJA Educ. 2016; 16: 276-280
        • Al-Rifai Z.
        • Mulvey D.
        Principles of total intravenous anaesthesia: basic pharmacokinetics and model descriptions.
        BJA Educ. 2016; 16: 92-97
        • Turner R.J.
        • Lambros M.
        • Holmes C.
        • et al.
        The effects of sevoflurane on isolated gravid human myometrium.
        Anaesth Intensive Care. 2002; 30: 591-596
        • Yildiz K.
        • Dogru K.
        • Dalgic H.
        • et al.
        Inhibitory effects of desflurane and sevoflurane on oxytocin-induced contractions of isolated pregnant human myometrium.
        Acta Anaesthesiol Scand. 2005; 49: 1355-1359
        • Butwick A.J.
        • Carvalho B.
        • El-Sayed Y.Y.
        Risk factors for obstetric morbidity in patients with uterine atony undergoing Caesarean delivery.
        Br J Anaesth. 2014; 113: 661-668
        • Shin Y.K.
        • Kim Y.D.
        • Collea J.V.
        The effect of propofol on isolated human pregnant uterine muscle.
        Anesthesiology. 1998; 89: 105-109
        • Thind A.S.
        • Turner R.J.
        In vitro effects of propofol on gravid human myometrium.
        Anaesth Intensive Care. 2008; 36: 802-806
        • Yamanoue T.
        • Brum J.M.
        • Estafanous F.G.
        Vasodilation and mechanism of action of propofol in porcine coronary artery.
        Anesthesiology. 1994; 81: 443-451
        • Chang K.S.K.
        • Davis R.F.
        Propofol produces endothelium-independent vasodilation and may act as a Ca2+ channel blocker.
        Anesth Analg. 1993; 76: 24-32
        • Petros A.J.
        • Bogle R.G.
        • Pearson J.D.
        Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells.
        Br J Pharmacol. 1993; 109: 6-7
        • Nimmo A.F.
        • Absalom A.R.
        • Bagshaw O.
        • et al.
        Guidelines for the safe practice of total intravenous anaesthesia (TIVA): Joint Guidelines from the Association of Anaesthetists and the Society for Intravenous Anaesthesia.
        Anaesthesia. 2019; 74: 211-224
        • Hall J.E.
        • Ng W.S.
        • Smith S.
        Blood loss during first trimester termination of pregnancy: comparison of two anaesthetic techniques.
        Br J Anaesth. 1997; 78: 172-174
        • Ciechanowicz S.
        • Setty T.
        • Robson E.
        • et al.
        Development and evaluation of an obstetric quality-of-recovery score (ObsQoR-11) after elective Caesarean delivery.
        Br J Anaesth. 2019; 122: 69-78
        • Ciechanowicz S.
        • Howle R.
        • Heppolette C.
        • et al.
        Evaluation of the Obstetric Quality-of-Recovery score (ObsQoR-11) following non-elective caesarean delivery.
        Int J Obstet Anesth. 2019; 39: 51-59
        • Balki M.
        • Carvalho J.C.A.
        Intraoperative nausea and vomiting during cesarean section under regional anesthesia.
        Int J Obstet Anesth. 2005; 14: 230-241
        • Dershwitz M.
        • Michalowski P.
        • Chang Y.C.
        • Rosow C.E.
        • Conlay L.A.
        Postoperative nausea and vomiting after total intravenous anesthesia with propofol and remifentanil or alfentanil: How important is the opioid?.
        J Clin Anesth. 2002; 14: 275-278
        • Chandrakantan A.
        • Glass P.S.A.
        Multimodal therapies for postoperative nausea and vomiting, and pain.
        Br J Anaesth. 2011; 107: 27-40
        • Lee W.K.
        • Kim M.S.
        • Kang S.W.
        • Kim S.
        • Lee J.R.
        Type of anaesthesia and patient quality of recovery: A randomized trial comparing propofol-remifentanil total i.v. anaesthesia with desflurane anaesthesia.
        Br J Anaesth. 2015; 114: 663-668
        • Yu E.H.
        • Tran D.H.
        • Lam S.W.
        • Irwin M.G.
        Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain?.
        Anaesthesia. 2016; 71: 1347-1362
        • Fletcher D.
        • Martinez V.
        Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis.
        Br J Anaesth. 2014; 112: 991-1004
        • Singh N.P.
        • Monks D.
        • Makkar J.K.
        • et al.
        Efficacy of regional blocks or local anaesthetic infiltration for analgesia after caesarean delivery: a network meta-analysis of randomised controlled trials.
        Anaesthesia. 2022; 77: 463-474
        • Watts N.
        • Amann M.
        • Arnell N.
        • et al.
        The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises.
        Lancet. 2021; 397: 129-170
        • McGain F.
        • Muret J.
        • Lawson C.
        • Sherman J.D.
        Environmental sustainability in anaesthesia and critical care.
        Br J Anaesth. 2020; 125: 680-692
        • Ryan S.M.
        • Nielsen C.J.
        Global warming potential of inhaled anesthetics: application to clinical use.
        Anesth Analg. 2010; 111: 92-98
        • Odor P.M.
        • Bampoe S.
        • Moonesinghe S.R.
        • et al.
        General anaesthetic and airway management practice for obstetric surgery in England: a prospective, multicentre observational study.
        Anaesthesia. 2021; 76: 460-471
        • Sherman J.
        • Le C.
        • Lamers V.
        • Eckelman M.
        Life cycle greenhouse gas emissions of anesthetic drugs.
        Anesth Analg. 2012; 114: 1086-1090
      1. Malignant hyperthermia during pregnancy – European Malignant Hyperthermia Group. Available at: https://www.emhg.org/recommendations-1/mh-during-pregnancy. Accessed January 1, 2022.

        • Frassanito L.
        • Vagnoni S.
        • Zanfini B.A.
        • et al.
        General anesthesia for caesarean delivery in a pregnant woman affected by acute myocardial infarction.
        Eur Rev Med Pharmacol Sci. 2012; 16: 1123-1126
        • McCarroll C.P.
        • Paxton L.D.
        • Elliott P.
        • Wilson D.B.
        Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section.
        Br J Anaesth. 2001; 86: 135-138
        • Orme R.M.L.E.
        • Grange C.S.
        • Ainsworth Q.P.
        • Grebenik C.R.
        General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: A series of four cases.
        Int J Obstet Anesth. 2004; 13: 183-187
        • Fujita M.
        • Satsumae T.
        • Tanaka M.
        General anesthesia using remifentanil for Cesarean section in a parturient with Marfan syndrome associated with heart failure due to severe mitral regurgitation.
        Masui. 2016; 65: 530-534
        • Mertens E.
        • Saldien V.
        • Coppejans H.
        • Bettens K.
        • Vercauteren M.
        Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension.
        Acta Anaesthesiol Belg. 2001; 52: 207-209
        • Macfarlane A.J.R.
        • Moise S.
        • Smith D.
        Caesarean section using total intravenous anaesthesia in a patient with Ebstein’s anomaly complicated by supraventricular tachycardia.
        Int J Obstet Anesth. 2007; 16: 155-159
        • Manullang T.R.
        • Chun K.
        • Egan T.D.
        The use of remifentanil for Cesarean section in a parturient with recurrent aortic coarctation.
        Can J Anesth. 2000; 47: 454-459
        • Llopis J.E.
        • Garcia-Aguado R.
        • Sifre C.
        • et al.
        Total intravenous anaesthesia for caesarean section in a patient with Marfan’s syndrome.
        Int J Obstet Anesth. 1997; 6: 59-62
      2. Lubeigt O, Jadhav R, Reeve B. A seven-year review of obstetric patients delivering at a tertiary cardiac centre. Unpublished posters, P89: Obstetric Anaesthesia 2016 (Manchester):P1.

        • Anson J.A.
        • Vaida S.
        • Giampetro D.M.
        • McQuillan P.M.
        Anesthetic management of labor and delivery in patients with elevated intracranial pressure.
        Int J Obstet Anesth. 2015; 24: 147-160
        • Hodgkinson R.
        • Husain F.J.
        • Hayashi R.H.
        Systemic and pulmonary blood pressure during caesarean section in parturients with gestational hypertension.
        Can Anaesth Soc J. 1980; 27: 389-394
        • Park B.Y.
        • Jeong C.W.
        • Jang E.A.
        • et al.
        Dose-related attenuation of cardiovascular responses to tracheal intubation by intravenous remifentanil bolus in severe pre-eclamptic patients undergoing Caesarean delivery.
        Br J Anaesth. 2011; 106: 82-87
        • Feghali M.
        • Venkataramanan R.
        • Caritis S.
        Pharmacokinetics of drugs in pregnancy.
        Semin Perinatol. 2015; 39: 512-519
        • Higuchi H.
        • Adachi Y.
        • Arimura S.
        • Kanno M.
        • Satoh T.
        Early pregnancy does not reduce the C50 of propofol for loss of consciousness.
        Anesth Analg. 2001; 93: 1565-1569
        • Smith J.A.
        • Donepudi R.V.
        • Argoti P.S.
        • et al.
        Exploring the pharmacokinetic profile of remifentanil in mid-trimester gestations undergoing fetal intervention procedures.
        Front Pharmacol. 2017; 8: 11
        • Pandit J.J.
        • Andrade J.
        • Bogod D.G.
        • et al.
        5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: Summary of main findings and risk factors.
        Br J Anaesth. 2014; 113: 549-559
        • Odor P.M.
        • Bampoe S.
        • Lucas D.N.
        • et al.
        Incidence of accidental awareness during general anaesthesia in obstetrics: a multicentre, prospective cohort study.
        Anaesthesia. 2021; 76: 759-776
        • Bonnet M.P.
        • Mercier F.J.
        • Vicaut E.
        • et al.
        Incidence and risk factors for maternal hypoxaemia during induction of general anaesthesia for non-elective Caesarean section: a prospective multicentre study.
        Br J Anaesth. 2020; 125: e81-e87
        • Tomlinson J.M.B.
        • Bishop D.G.
        • Hofmeyr R.
        • Cronjé L.
        • Rodseth R.N.
        The incidence and predictors of hypoxaemia during induction of general anaesthesia for caesarean delivery in two South African hospitals: A prospective, observational, dual-centre study.
        South Afr J Anaesth Analg. 2020; 26: 183-187
        • Nimmo A.F.
        • Absalom A.R.
        • Bagshaw O.
        • et al.
        Guidelines for the safe practice of total intravenous anaesthesia (TIVA).
        Anaesthesia. 2019; 74: 211-224https://doi.org/10.1111/ANAE.14428
        • Hajat Z.
        • Ahmad N.
        • Andrzejowski J.
        The role and limitations of EEG-based depth of anaesthesia monitoring in theatres and intensive care.
        Anaesthesia. 2017; 72: 38-47
        • Paech M.J.
        • Scott K.L.
        • Clavisi O.
        • Chua S.
        • McDonnell N.
        A prospective study of awareness and recall associated with general anaesthesia for caesarean section.
        Int J Obstet Anesth. 2008; 17: 298-303
        • Tunstall M.E.
        Detecting wakefulness during general anaesthesia for caesarean section.
        Br Med J. 1977; 1: 1321
        • Zand F.
        • Hadavi S.M.R.
        • Chohedri A.
        • Sabetian P.
        Survey on the adequacy of depth of anaesthesia with bispectral index and isolated forearm technique in elective Caesarean section under general anaesthesia with sevoflurane.
        Br J Anaesth. 2014; 112: 871-878
        • Sánchez-Alcaraz A.
        • Quintana M.B.
        • Laguarda M.
        Placental transfer and neonatal effects of propofol in caesarean section.
        J Clin Pharm Ther. 1998; 23: 19-23
        • Kan R.E.
        • Hughes S.C.
        • Rosen M.A.
        • et al.
        Intravenous remifentanil: placental transfer, maternal and neonatal effects.
        Anesthesiology. 1998; 88: 1467-1474
        • White L.D.
        • Hodsdon A.
        • An G.H.
        • et al.
        Induction opioids for caesarean section under general anaesthesia: a systematic review and meta-analysis of randomised controlled trials.
        Int J Obstet Anesth. 2019; 40: 4-13
        • Foster R.N.
        • Boothroyd K.P.
        Caesarean section in a complicated case of central core disease.
        Anaesthesia. 2008; 63: 544-547
        • Xiao W.
        • Zhao L.
        • Wang F.
        • et al.
        Total intravenous anesthesia without muscle relaxant in a parturient with amyotrophic lateral sclerosis undergoing cesarean section: a case report.
        J Clin Anesth. 2017; 36: 107-109
        • Niki A.
        • Ochiai D.
        • Iwai M.
        • et al.
        Management of pregnancy complicated by central core disease.
        Int J Obstet Anesth. 2020; 43: 25-26
      3. Teixeira CEF de A, Braga A de F de A, Braga FS da S, et al. Anesthesia for cesarean delivery in a patient with Klippel‐Trenaunay syndrome. Braz J Anesthesiol. 2018;68:641–644.

        • Van de Velde M.
        • Teunkens A.
        • Kuypers M.
        • Dewinter T.
        • Vandermeersch E.
        General anaesthesia with target controlled infusion of propofol for planned caesarean section: Maternal and neonatal effects of a remifentanil-based technique.
        Int J Obstet Anesth. 2004; 13: 153-158